HPR93 Analysis of Real-World Evidence Role in US FDA Approvals of Novel Drugs and Post Marketing Requirements of RWE Study (Novel Drug Approvals US FDA 2023).

Autor:	Sachdeva, S1 (AUTHOR), Kaneria, J2 (AUTHOR), Shah, RS1 (AUTHOR)
Zdroj:	Value in Health. 2024 Supplement, Vol. 27 Issue 12, pS293-S293. 1p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect